Wird geladen...
Extended Half-Life Coagulation Factors: A New Era in the Management of Hemophilia Patients
Despite effective factor replacement and various treatment schedules, there remain several challenges and unmet needs in the prophylactic treatment of hemophilia limiting its adoption and thereby posing an increased risk of spontaneous bleeding. In this regard, extended half-life (EHL) recombinant f...
Gespeichert in:
| Veröffentlicht in: | Turk J Haematol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Galenos Publishing
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6682782/ https://ncbi.nlm.nih.gov/pubmed/31088040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.galenos.2019.2018.0393 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|